The Duke Cancer Institute’s (DCI) DNA Analysis/Automated Sequencing and Phosphorimaging Shared Resource and the Institute for Genome Sciences & Policy’s (IGSP) Sequencing Facility Core are collaborating to offer expanded sequencing services for cancer researchers.
Cancer Institute members are provided DCI Core Facility rates for services provided by the DNA Analysis/Automated Sequencing and Phosphorimaging Shared Resource but not the IGSP Genome Sequencing & Analysis Core Facility.
Fluorescent fragment analysis
Michael S. Krangel, PhD
Scott Langdon, PhD
135 Jones Building
Next-generation ultra-high throughput sequencing general services
The following are available on all four technologies listed below, including Sanger sequencing.
Roche GS-FLX (454) ultra-high throughput sequencing
Illumina Genome Analyzer II & IIx ultra-high throughput sequencing
AppliedBio SOLiD 4 ultra-high throughput sequencing
Capillary sequencing and misc.